Clinical trial · Interventional
Increasing Access to Definitive Treatment for Prostate Cancer
Increasing Access to Definitive Treatment for Prostate Cancer by Removing Transportation Barriers for UnderservedPatients: A Multilevel Feasibility Study
NCT06034431CI-TRIAL-00069626unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators will address the overarching challenge of advancing health equity and reducing disparities in prostate cancer by informing efforts to reduce travel burden in prostate cancer (PCa) treatment access among Black men.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ride Share | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Ride Share Participants
- description
- Investigators will recruit Black men with intermediate or high-risk PC who are seeking definitive treatment at Mass General Brigham Prostate Cancer Outreach Clinic, as Black men are more likely to report travel burden when accessing care and, therefore, most likely to benefit from ridesharing services. Investigators will implement a pre/post-evaluation design with matched historical controls to estimate the impact of rideshares on reducing missed appointments. Historical controls will be sampled from the pre-intervention period of April 2022 to September 2024 and the post-intervention period between October 2024 and November 2025, where October 2024 represents the initiation of the intervention. Participants who identify as Black, reside in a census tract in Massachusetts, and have been recognized as having a high travel burden based on results from Aim 1 will be eligible to receive the rideshare intervention
- interventionNames
- Other: Ride Share
Primary outcomes (1)
- measure
- Number of participants receiving definitive treatment within 90 days of diagnosis
- timeFrame
- Within 90 days of diagnosis
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 22 Years
Show eligibility criteria text
Inclusion Criteria: * Black man * Intermediate-or high-risk prostate cancer * Seeking prostate cancer definitive treatment (surgery or radiation) at the Mass General Brigham Prostate Cancer Outreach Clinic * Reside in a census tract in Massachusetts recognized as having a high travel burden based on results of Aim1 of the Project OR identifies as having difficulties or challenges when it comes to transportation, particularly in relation to getting to and from medical appointments Exclusion Criteria: None
References
Publications (0)
Data not yet available
No reference posted for this study.